SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-112440
Filing Date
2020-10-06
Accepted
2020-10-06 08:32:28
Documents
1
Period of Report
2020-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2032522d1_8k.htm 8-K 19948
  Complete submission text file 0001104659-20-112440.txt   21410
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 201225625
SIC: 2834 Pharmaceutical Preparations